X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
of-pediatric-oncology (106) 106
humans (94) 94
oncology (78) 78
child (71) 71
child, preschool (59) 59
male (58) 58
female (55) 55
infant (55) 55
chemotherapy (52) 52
index medicus (50) 50
adolescent (47) 47
pediatrics (42) 42
children (38) 38
combined modality therapy (33) 33
prognosis (33) 33
phase-ii (29) 29
treatment outcome (28) 28
antineoplastic combined chemotherapy protocols - therapeutic use (27) 27
radiotherapy (27) 27
international-society (25) 25
hematology (24) 24
childhood (23) 23
cancer (22) 22
retrospective studies (20) 20
risk factors (20) 20
carboplatin (19) 19
disease-free survival (19) 19
infant, newborn (19) 19
french-society (18) 18
rhabdomyosarcoma (18) 18
neoplasm staging (17) 17
surgery (17) 17
clinical neurology (16) 16
nephroblastoma (16) 16
etoposide (15) 15
kidney neoplasms - therapy (14) 14
soft-tissue sarcoma (14) 14
survival analysis (14) 14
survival rate (14) 14
therapy (14) 14
tumors (14) 14
wilms tumor - therapy (14) 14
adult (13) 13
care and treatment (13) 13
follow-up studies (13) 13
high-dose chemotherapy (13) 13
medicine & public health (13) 13
wilms tumor - pathology (13) 13
antineoplastic agents - therapeutic use (12) 12
intergroup rhabdomyosarcoma (12) 12
prognostic-factors (12) 12
stem-cell rescue (12) 12
analysis (11) 11
preoperative chemotherapy (11) 11
survival (11) 11
adjuvant chemotherapy (10) 10
brain-tumors (10) 10
cancer-study-group (10) 10
kidney neoplasms - pathology (10) 10
radiation-therapy (10) 10
recurrence (10) 10
vincristine - administration & dosage (10) 10
wilms tumor - drug therapy (10) 10
age factors (9) 9
health aspects (9) 9
kidney neoplasms - drug therapy (9) 9
low-grade glioma (9) 9
management (9) 9
neoplasm recurrence, local - therapy (9) 9
nonmetastatic rhabdomyosarcoma (9) 9
prognostic factors (9) 9
radiotherapy dosage (9) 9
brain neoplasms - pathology (8) 8
chemotherapy, adjuvant (8) 8
childrens cancer group (8) 8
etoposide - administration & dosage (8) 8
gliomas (8) 8
magnetic resonance imaging (8) 8
medulloblastoma (8) 8
neuroblastoma (8) 8
research (8) 8
solid tumors (8) 8
wilms tumor (8) 8
age (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
bone-marrow-transplantation (7) 7
carboplatin - administration & dosage (7) 7
childrens oncology group (7) 7
craniospinal radiation-therapy (7) 7
cyclophosphamide - administration & dosage (7) 7
diagnosis (7) 7
follow-up (7) 7
ifosfamide (7) 7
kidney neoplasms - mortality (7) 7
medulloblastoma - radiotherapy (7) 7
neoplasm recurrence, local - mortality (7) 7
neuroblastoma - drug therapy (7) 7
postoperative chemotherapy (7) 7
prospective randomized-trial (7) 7
radiology, nuclear medicine & medical imaging (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 09/2006, Volume 24, Issue 25, pp. 4202 - 4208
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2010, Volume 28, Issue 2, pp. 318 - 323
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 07/2018, Volume 68, pp. 94 - 101
We review and summarize the highlights of almost five decades of cooperative group trials in rhabdomyosarcoma on both sides of the Atlantic, concentrating on... 
Clinical trials | Rhabdomyosarcoma | STEM-CELL RESCUE | INTERNATIONAL-SOCIETY | PHASE-II WINDOW | INTERGROUP-RHABDOMYOSARCOMA | NONMETASTATIC RHABDOMYOSARCOMA | DIAGNOSED METASTATIC RHABDOMYOSARCOMA | ONCOLOGY | HIGH-DOSE CHEMOTHERAPY | OF-PEDIATRIC-ONCOLOGY | LOW-RISK RHABDOMYOSARCOMA | SOFT-TISSUE SARCOMA | Chemotherapy | Anthracyclines | Stem cells | Cancer
Journal Article
Neuro-Oncology, ISSN 1522-8517, 01/2013, Volume 15, Issue 1, pp. 97 - 103
The purpose of the trial was to determine the survival and incidence of secondary tumors in children with medulloblastoma receiving radiotherapy plus... 
secondary tumors | radiotherapy | medulloblastoma | chemotherapy | CRANIOSPINAL RADIATION-THERAPY | PROSPECTIVE RANDOMIZED-TRIAL | INTERNATIONAL-SOCIETY | RISK MEDULLOBLASTOMA | PROGNOSTIC-FACTORS | PHASE-III | CLINICAL NEUROLOGY | BRAIN-TUMORS | MULTICENTER TRIAL | ONCOLOGY | OF-PEDIATRIC-ONCOLOGY | MALIGNANT NEOPLASMS | Cyclophosphamide - administration & dosage | Prognosis | Follow-Up Studies | Humans | Child, Preschool | Infant | Male | Medulloblastoma - therapy | Neoplasms, Second Primary - mortality | Medulloblastoma - mortality | Neoplasm Recurrence, Local - mortality | Chemoradiotherapy | Cisplatin - administration & dosage | Incidence | Young Adult | Cerebellar Neoplasms - epidemiology | Neoplasms, Second Primary - therapy | District of Columbia - epidemiology | Vincristine - administration & dosage | Adult | Female | Chemotherapy, Adjuvant | Child | Radiotherapy Dosage | Neoplasm Recurrence, Local - therapy | Cerebellar Neoplasms - mortality | Survival Rate | Cranial Irradiation | Medulloblastoma - epidemiology | Neoplasms, Second Primary - epidemiology | Magnetic Resonance Imaging | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Neoplasm Recurrence, Local - epidemiology | Cerebellar Neoplasms - therapy | Lomustine - administration & dosage | Cohort Studies | Clinical Investigations
Journal Article
Cancer, ISSN 0008-543X, 02/2012, Volume 118, Issue 4, pp. 1130 - 1137
BACKGROUND: Patients aged >10 years with rhabdomyosarcoma have an inferior outcome compared with patients ages 1 to 9 years, which may be explained by... 
toxicity | adolescent | rhabdomyosarcoma | chemotherapy | age | sex | INTERGROUP RHABDOMYOSARCOMA | CLINICAL-TRIAL | CYCLOPHOSPHAMIDE | COMMITTEE | CHILDHOOD | TUMORS | PHARMACOKINETICS | ONCOLOGY | VINCRISTINE | OF-PEDIATRIC-ONCOLOGY | SOFT-TISSUE SARCOMA | Chemotherapy | Usage | Rhabdomyosarcoma | Research | Pharmacokinetics | Drug therapy | Cancer | Adolescence
Journal Article
Journal Article
Journal Article
Journal Article
15.